MX9701331A - Metodos para mantener los dientes y los huesos bucales. - Google Patents

Metodos para mantener los dientes y los huesos bucales.

Info

Publication number
MX9701331A
MX9701331A MX9701331A MX9701331A MX9701331A MX 9701331 A MX9701331 A MX 9701331A MX 9701331 A MX9701331 A MX 9701331A MX 9701331 A MX9701331 A MX 9701331A MX 9701331 A MX9701331 A MX 9701331A
Authority
MX
Mexico
Prior art keywords
methods
maintaining teeth
oral bone
teeth
maintaining
Prior art date
Application number
MX9701331A
Other languages
English (en)
Inventor
William Lockridge Sales
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX9701331A publication Critical patent/MX9701331A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

La presente invencion describe un método para mantener los dientes y los huesos bucales, que comprende administrar a un humano que la necesita una cantidad efectiva de un compuesto que tiene la formula (I), en donde R1 y R3 son independientemente hidrogeno, -CH3, (a) o (b), en donde Ar es fenilo opcionalmente substituido; R2 se selecciona del grupo que consiste de pirrolidina, haxametilenimino, y piperidino; u una sal o solvato del mismo farmacéuticamente aceptable.
MX9701331A 1994-08-22 1995-08-21 Metodos para mantener los dientes y los huesos bucales. MX9701331A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29423794A 1994-08-22 1994-08-22
PCT/US1995/010582 WO1996005829A1 (en) 1994-08-22 1995-08-21 Methods of maintaining teeth and oral bone

Publications (1)

Publication Number Publication Date
MX9701331A true MX9701331A (es) 1997-05-31

Family

ID=23132491

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9701331A MX9701331A (es) 1994-08-22 1995-08-21 Metodos para mantener los dientes y los huesos bucales.

Country Status (14)

Country Link
EP (1) EP0769946A4 (es)
JP (1) JPH10504573A (es)
KR (1) KR970705386A (es)
AU (1) AU692598B2 (es)
CA (1) CA2198108A1 (es)
CZ (1) CZ52197A3 (es)
FI (1) FI970713A7 (es)
HU (1) HUT76891A (es)
IL (1) IL115017A0 (es)
MX (1) MX9701331A (es)
NO (1) NO970784L (es)
WO (1) WO1996005829A1 (es)
YU (1) YU55495A (es)
ZA (1) ZA956987B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss

Also Published As

Publication number Publication date
WO1996005829A1 (en) 1996-02-29
EP0769946A4 (en) 1997-11-05
AU692598B2 (en) 1998-06-11
ZA956987B (en) 1997-02-21
NO970784D0 (no) 1997-02-20
NO970784L (no) 1997-02-20
CA2198108A1 (en) 1996-02-29
FI970713A0 (fi) 1997-02-20
EP0769946A1 (en) 1997-05-02
CZ52197A3 (en) 1997-08-13
IL115017A0 (en) 1995-12-08
FI970713L (fi) 1997-02-20
HUT76891A (en) 1997-12-29
JPH10504573A (ja) 1998-05-06
YU55495A (sh) 1998-07-10
AU3408895A (en) 1996-03-14
KR970705386A (ko) 1997-10-09
FI970713A7 (fi) 1997-02-20

Similar Documents

Publication Publication Date Title
ES2157957T3 (es) Procedimientos para inhibir la endometriosis.
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
MX9701329A (es) Metodos para la inhibicion de la replicacion viral.
DK0651999T3 (da) Fremgangsmåder til inhibering af livmoderfibrose
ES2157960T3 (es) Procedimiento para aumentar la libido en mujeres postmenopausicas.
DK0659417T3 (da) Fremgangsmåder til inhibering af dysfunktionel blødning fra livmoderen
DK0652002T3 (da) Anvendelse af 2-phenyl-3-aroylebenzothiophener til fremstilling af et medikament til hæmning af brusknedbrydning
MX9701334A (es) Metodos para inhibir la degeneracion de protesis oseas.
EA199700136A1 (ru) Способы ингибирования экзогенных эстрогенов
MX9701331A (es) Metodos para mantener los dientes y los huesos bucales.
MX9701332A (es) Metodos para curar y reparar fracturas oseas.
MX9702148A (es) Metodos para inhibir la mitosis endometrial.
MX9702861A (es) Metodo para inhibir las condiciones asociadas con la bradicinina.
DK0771201T3 (da) Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et medikament til inhibering af primær endometrisk hyperplasi
MX9705215A (es) Uso de 2-fenil-3-aroilbenzotiofenos para inhibir los efectos de la hormona del crecimiento.
MX9702853A (es) Metodos para inhibir condiciones asociadas con el neuropeptido "y".
RU97104094A (ru) Способ предотвращения деградации костного протеза
MX9701328A (es) Metodos de reduccion de la cicatrizacion en la curacion de heridas.
MX9706520A (es) Metodos para inhibir el cancer de ovario.
MX9705940A (es) Metodos y composiciones para inhibir los efectos de la interleucina 6.
MX9709536A (es) Metodo para reducir el factor de transcripcion bef-1.